Trevigen Launches Cultrex BME PathClear

Released on: January 8, 2008, 6:11 pm

Press Release Author: Trevigen, Inc.

Industry: Biotech

Press Release Summary: Trevigen is pleased to announce the immediate availability of
PathClear\" Basement Membrane Extract in the Cultrex® product line.

Press Release Body:
Trevigen Launches Cultrex BME PathClear
Gaithersburg, MD, United States - Cultrex® BME PathClear\"


Trevigen is pleased to announce the immediate availability of PathClear\" Basement
Membrane Extract in the Cultrex® product line.

The PathClear\" designation means that in addition to standard sterility, endotoxin
and MAP testing, the BME is tested by PCR and is clear of a battery of 31 pathogens,
including LDEV. Each lot is rigorously qualified in biological performance assays.
Available in reduced growth factor form, with and without phenol red, PathClear\" BME
is expected to be of special interest for in vivo murine research work and other
work requiring BME free from viruses, bacteria and mycoplasma.

Trevigen, Inc. develops, manufactures and markets an extensive line of Cultrex®
brand products for the promotion of cell growth, cellular differentiation and for
the study of cancer cell behavior. For more information, see www.trevigen.com.




Web Site: http://www.trevigen.com

Contact Details: Press Contact:
Belinda de Leon
Trevigen, Inc.
www.trevigen.com
301-216-2800
info@trevigen.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •